Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy

BACKGROUND: Statins may reduce the risk of first and recurrent venous thromboembolism (VTE). No data are available on their potential benefit in patients treated with the oral anticoagulant rivaroxaban. METHODS: The EINSTEIN DVT/PE and EINSTEIN Extension studies compared rivaroxaban with standard of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wells, Philip S, Gebel, Martin, Prins, Martin H, Davidson, Bruce L, Lensing, Anthonie WA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Original Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334416/
https://www.ncbi.nlm.nih.gov/pubmed/25698905
http://dx.doi.org/10.1186/1477-9560-12-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334416/
https://www.ncbi.nlm.nih.gov/pubmed/25698905
http://dx.doi.org/10.1186/1477-9560-12-26

Ejemplares similares